
Global PCR-based Enteric Disease Testing Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global PCR-based Enteric Disease Testing market size will reach US$ million by 2031.
United States market for PCR-based Enteric Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for PCR-based Enteric Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for PCR-based Enteric Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key PCR-based Enteric Disease Testing players cover Thermo Fisher Scientific, Vela Diagnostics, CorisBioconcept, Meridian Life Science, Bio-Rad Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “PCR-based Enteric Disease Testing Industry Forecast” looks at past sales and reviews total world PCR-based Enteric Disease Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected PCR-based Enteric Disease Testing sales for 2025 through 2031. With PCR-based Enteric Disease Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PCR-based Enteric Disease Testing industry.
This Insight Report provides a comprehensive analysis of the global PCR-based Enteric Disease Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on PCR-based Enteric Disease Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PCR-based Enteric Disease Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PCR-based Enteric Disease Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PCR-based Enteric Disease Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of PCR-based Enteric Disease Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Analyzers/Instruments
Kits/Panels
Segmentation by Application:
Clostridium Difficile
Campylobacteriosis
Cholera
E. coli Infection
H. pylori Infection
Salmonellosis
Shigellosis
Rotavirus Infection
Norovirus Infection
Parasitic Enteric Disease
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Vela Diagnostics
CorisBioconcept
Meridian Life Science
Bio-Rad Laboratories
Abbott (ALERE)
bioMerieux SA
Trinity Biotech
DiaSorin Molecular
Etta Healthcare (Ovagene Oncology)
ExcitePCR (PositiveID Corporation)
Flow Alliance
Fluid-Screen
FluimediX
Fluxergy
Focus Diagnostics (DiaSorin Molecular)
Future Horizon Scientific
Genalyte
GeneFluidics
GenSpeed Biotech
Gulf Bio Analytical
Hahn-Schickard
Helvoet
HemoCue
Danaher
IDEX Health&Science
iLine Microsystems
Inflammatix
Please note: The report will take approximately 2 business days to prepare and deliver.
United States market for PCR-based Enteric Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for PCR-based Enteric Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for PCR-based Enteric Disease Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key PCR-based Enteric Disease Testing players cover Thermo Fisher Scientific, Vela Diagnostics, CorisBioconcept, Meridian Life Science, Bio-Rad Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “PCR-based Enteric Disease Testing Industry Forecast” looks at past sales and reviews total world PCR-based Enteric Disease Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected PCR-based Enteric Disease Testing sales for 2025 through 2031. With PCR-based Enteric Disease Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PCR-based Enteric Disease Testing industry.
This Insight Report provides a comprehensive analysis of the global PCR-based Enteric Disease Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on PCR-based Enteric Disease Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PCR-based Enteric Disease Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PCR-based Enteric Disease Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PCR-based Enteric Disease Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of PCR-based Enteric Disease Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Analyzers/Instruments
Kits/Panels
Segmentation by Application:
Clostridium Difficile
Campylobacteriosis
Cholera
E. coli Infection
H. pylori Infection
Salmonellosis
Shigellosis
Rotavirus Infection
Norovirus Infection
Parasitic Enteric Disease
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Vela Diagnostics
CorisBioconcept
Meridian Life Science
Bio-Rad Laboratories
Abbott (ALERE)
bioMerieux SA
Trinity Biotech
DiaSorin Molecular
Etta Healthcare (Ovagene Oncology)
ExcitePCR (PositiveID Corporation)
Flow Alliance
Fluid-Screen
FluimediX
Fluxergy
Focus Diagnostics (DiaSorin Molecular)
Future Horizon Scientific
Genalyte
GeneFluidics
GenSpeed Biotech
Gulf Bio Analytical
Hahn-Schickard
Helvoet
HemoCue
Danaher
IDEX Health&Science
iLine Microsystems
Inflammatix
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
173 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 PCR-based Enteric Disease Testing Market Size by Player
- 4 PCR-based Enteric Disease Testing by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global PCR-based Enteric Disease Testing Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.